Larson Financial Group »

Werewolf Therapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Werewolf Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Werewolf Therapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Werewolf Therapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.3k 13k 0.63
2025-09-30 $20k 10k 1.97
2025-06-30 $11k 10k 1.09
2025-03-31 $9.7k 10k 0.97
2024-12-31 $15k 10k 1.48

More positions owned by Larson Financial Group

Spdr Series Trust State Street Spd (SPYM)
Apple (AAPL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Capital Group Global Equity SHS (CGGE)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Microsoft Corporation (MSFT)
Ishares Tr Msci Intl Qualty (IQLT)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Applied Materials (AMAT)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Pgim Etf Tr Active Aggregate (PAB)

View all positions for Larson Financial Group

Top funds holding Werewolf Therapeutics

RA Capital Management
MPM Asset Management
Vanguard Group
MPM Oncology Impact Management
Renaissance Technologies
Lynx1 Capital Management
Sphera Funds Management
DC Funds
Partner Fund Management
Geode Capital Management
Millennium Management
Alyeska Investment Group
Jane Street
Citadel Advisors
State Street Corporation

View all funds holding Werewolf Therapeutics